Oncolytic Virus Immunotherapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Oncolytic Virus Immunotherapy Market is expected to grow at a CAGR of 12% during the forecast period of 2022-2028.

Oncolytic viral immunotherapy involves the use of a virus to infect and subsequently kill cancer cells. Cancer cells are known to have compromised antiviral defenses, making them more susceptible to infection than normal cells in the body. Oncolytic viruses are engineered in such a way that their ability to infect healthy cells is reduced while simultaneously delivering a therapeutic payload to tumor cells. This in turn increases the production of immune enhancing molecules. After infection, the oncolytic virus ruptures the cancer cells, eventually eradicating the cells. This leads to the release of cancer antigens that can further stimulate an immune response. Cancer antigens also help get rid of any remaining tumor cells in the body.

Market Segments

By Product Type

• HSV-based Oncolytic Viruses
• Adenovirus-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses

By Application

• Melanoma
• Bladder Cancer
• Prostate Cancer
• Ovarian Cancer
• Lung Cancer
• Breast Cancer
• Myeloma

Key Players

• BioVex, Inc. (Amgen, Inc.)
• Cold Genesys, Inc. 
• DNAtrix Therapeutics 
• Genelux Corporation 
• Lokon Pharma AB 
• Oncolytics Biotech, Inc. 
• ORYX GmbH & Co. KG 
• PsiOxus Therapeutics 
• SillaJen, Inc.
• Sorrento Therapeutics, Inc. 

Scope of the Report

The research study analyzes the global Oncolytic Virus Immunotherapy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Oncolytic Virus Immunotherapy Market Report

1. What was the Oncolytic Virus Immunotherapy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Oncolytic Virus Immunotherapy Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Oncolytic Virus Immunotherapy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.